Literature DB >> 16919984

Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung.

Masafumi Tomaki1, Hisatoshi Sugiura, Akira Koarai, Yuichi Komaki, Takefumi Akita, Tatsumi Matsumoto, Atsushi Nakanishi, Hiromasa Ogawa, Toshio Hattori, Masakazu Ichinose.   

Abstract

The involvement of inflammation in the pathogenesis of chronic obstructive pulmonary disease (COPD) has been investigated using samples from relatively central airways such as airway biopsies, but there have been fewer studies in the peripheral lung, which is thought to be the main site of the disease process. To determine the molecules that relate to the mechanisms underlying the pathogenesis of COPD, we evaluated the mRNA expression of inflammatory cytokines, chemokines, oxidant enzymes, antioxidant enzymes, proteinases and antiproteinases in peripheral lung tissues from 33 COPD and non-COPD subjects who were undergoing lung resection for lung cancer using an RT-PCR technique. Among the 42 studied candidate genes, the expressions of mRNA for catalase, glutathion S-transferase P1 (GSTP1), glutathion S-transferase M1 (GSTM1), microsomal epoxide hydrolase (mEPHX) and tissue inhibitor of metalloproteinase 2 (TIMP2) were significantly decreased in COPD lung tissues compared with those in non-COPD tissues, and most of these decreases were significantly correlated with the degree of airflow limitation. On the other hand, the expressions of mRNA for interleukin 1beta (IL-1beta), interleukin 8 (IL-8), growth-related oncogene-alpha (Gro-alpha) and monocyte chemotactic protein-1 (MCP-1) were significantly increased in COPD lungs. Most of these changes were also associated with cigarette smoking. These data suggest that an impairment of protective mechanisms against oxidants and xenobiotics, in addition to the upregulation of CXC- and CC-chemokines, may be associated with cigarette smoking and involved in the inflammatory process of COPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919984     DOI: 10.1016/j.pupt.2006.06.006

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  24 in total

1.  Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction.

Authors:  David Adenuga; Samuel Caito; Hongwei Yao; Isaac K Sundar; Jae-Woong Hwang; Sangwoon Chung; Irfan Rahman
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

Review 2.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

3.  Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease.

Authors:  Dina Schneider; Shyamala Ganesan; Adam T Comstock; Catherine A Meldrum; Raja Mahidhara; Adam M Goldsmith; Jeffrey L Curtis; Fernando J Martinez; Marc B Hershenson; Umadevi Sajjan
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

4.  The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis.

Authors:  Eileen L Heinrich; Tonya C Walser; Kostyantyn Krysan; Elvira L Liclican; Jeanette L Grant; Nicole L Rodriguez; Steven M Dubinett
Journal:  Cancer Microenviron       Date:  2011-09-16

Review 5.  Role of GSTM1 in resistance to lung inflammation.

Authors:  Weidong Wu; David Peden; David Diaz-Sanchez
Journal:  Free Radic Biol Med       Date:  2012-06-06       Impact factor: 7.376

6.  Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.

Authors:  A Khanna; M Guo; M Mehra; W Royal
Journal:  J Neuroimmunol       Date:  2012-09-30       Impact factor: 3.478

Review 7.  Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review.

Authors:  A R Bentley; P Emrani; P A Cassano
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

8.  Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner.

Authors:  Elizabeth A Rondini; Dianne M Walters; Alison K Bauer
Journal:  Part Fibre Toxicol       Date:  2010-04-12       Impact factor: 9.400

9.  DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways.

Authors:  Emily A Vucic; Raj Chari; Kelsie L Thu; Ian M Wilson; Allison M Cotton; Jennifer Y Kennett; May Zhang; Kim M Lonergan; Katrina Steiling; Carolyn J Brown; Annette McWilliams; Keishi Ohtani; Marc E Lenburg; Don D Sin; Avrum Spira; Calum E Macaulay; Stephen Lam; Wan L Lam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

10.  Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease.

Authors:  Anne H Agler; Ronald G Crystal; Jason G Mezey; Jennifer Fuller; Chuan Gao; Joyanna G Hansen; Patricia A Cassano
Journal:  COPD       Date:  2013-08       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.